SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-13-001457
Filing Date
2013-03-01
Accepted
2013-03-01 15:39:19
Documents
13

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1885483
2 filename2.htm EX-16 2008
3 GRAPHIC g483126g90c25.jpg GRAPHIC 43524
4 GRAPHIC g483126g06y10.jpg GRAPHIC 39915
5 GRAPHIC g483126g36d61.jpg GRAPHIC 30822
6 GRAPHIC g483126g44k50.jpg GRAPHIC 50528
7 GRAPHIC g483126g60q01.jpg GRAPHIC 23229
8 GRAPHIC g483126g69p67.jpg GRAPHIC 86996
9 GRAPHIC g483126g74p89.jpg GRAPHIC 60110
10 GRAPHIC g483126g77c95.jpg GRAPHIC 24018
11 GRAPHIC g483126g82w61.jpg GRAPHIC 33007
12 GRAPHIC g483126g88p91.jpg GRAPHIC 24202
13 GRAPHIC g483126g88s00.jpg GRAPHIC 32256
  Complete submission text file 0000950123-13-001457.txt   2508255
Mailing Address ONE KEW PLACE 150 ROUSE BOULEVARD PHILADELPHIA PA 19112
Business Address ONE KEW PLACE 150 ROUSE BOULEVARD PHILADELPHIA PA 19112 267-546-3003
Iroko Pharmaceuticals Inc. (Filer) CIK: 0001566717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-00120 | Film No.: 13657339
SIC: 2834 Pharmaceutical Preparations